내시경 시술 시 고려사항(길잡이): Novel Oral Anticoagulants 복용 중인 환자에서Guidance for Endoscopic Procedures in Patients Taking Novel Oral Anticoagulants
- Other Titles
- Guidance for Endoscopic Procedures in Patients Taking Novel Oral Anticoagulants
- Authors
- 김경오
- Issue Date
- 2016
- Publisher
- 대한상부위장관ㆍ헬리코박터학회
- Keywords
- Anticoagulants; Endoscopy; Gastrointestinal hemorrhage; Thromboembolism
- Citation
- Korean Journal of Helicobacter Upper Gastrointestinal Research, v.16, no.4, pp.185 - 188
- Journal Title
- Korean Journal of Helicobacter Upper Gastrointestinal Research
- Volume
- 16
- Number
- 4
- Start Page
- 185
- End Page
- 188
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/8998
- DOI
- 10.7704/kjhugr.2016.16.4.185
- ISSN
- 1738-3331
- Abstract
- Anticoagulant agents are used to reduce the risk of thromboembolic complications in patients with atrial fibrillation or deep vein thrombosis. Several new generation of oral anticoagulants have been approved. These novel oral anticoagulants (NOACs) include direct thrombin inhibitors, dabigatra etexilate, and the direct factor Xa inhibitors, rivaroxaban, apixaban and edoxaban. This review evaluates NOACs-related gastrointestinal bleeding and summarizes the ideal management strategies based on the guideline suggested by American Society for Gastrointestinal Endoscopy.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의학과 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.